114 related articles for article (PubMed ID: 18783939)
1. Metastatic renal cell carcinoma: results of a population-based study with 25 years follow-up.
Schlesinger-Raab A; Treiber U; Zaak D; Hölzel D; Engel J
Eur J Cancer; 2008 Nov; 44(16):2485-95. PubMed ID: 18783939
[TBL] [Abstract][Full Text] [Related]
2. No improvement in renal cell carcinoma survival: a population-based study in the Netherlands.
Aben KK; Luth TK; Janssen-Heijnen ML; Mulders PF; Kiemeney LA; van Spronsen DJ
Eur J Cancer; 2008 Aug; 44(12):1701-9. PubMed ID: 18502115
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients.
Naito S; Yamamoto N; Takayama T; Muramoto M; Shinohara N; Nishiyama K; Takahashi A; Maruyama R; Saika T; Hoshi S; Nagao K; Yamamoto S; Sugimura I; Uemura H; Koga S; Takahashi M; Ito F; Ozono S; Terachi T; Naito S; Tomita Y
Eur Urol; 2010 Feb; 57(2):317-25. PubMed ID: 19136199
[TBL] [Abstract][Full Text] [Related]
4. [Pulmonary resections for metastatic renal cell carcinoma in Iceland].
Oddsson SJ; Isaksson HJ; Jonsson E; Einarsson GV; Gudbjartsson T
Laeknabladid; 2008 May; 94(5):377-81. PubMed ID: 18460734
[TBL] [Abstract][Full Text] [Related]
5. Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma.
Zini L; Capitanio U; Perrotte P; Jeldres C; Shariat SF; Arjane P; Widmer H; Montorsi F; Patard JJ; Karakiewicz PI
Urology; 2009 Feb; 73(2):342-6. PubMed ID: 19041122
[TBL] [Abstract][Full Text] [Related]
6. Epidemiologic trends in renal cell carcinoma in the cytokine and post-cytokine eras: a registry analysis of 28,252 patients.
Shek D; Tomlinson B; Brown M; Brunson A; Pan CX; Lara PN
Clin Genitourin Cancer; 2012 Jun; 10(2):93-8. PubMed ID: 22382008
[TBL] [Abstract][Full Text] [Related]
7. Outcome of nephron-sparing surgery for T1b renal cell carcinoma.
Joniau S; Vander Eeckt K; Srirangam SJ; Van Poppel H
BJU Int; 2009 May; 103(10):1344-8. PubMed ID: 19040528
[TBL] [Abstract][Full Text] [Related]
8. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
[TBL] [Abstract][Full Text] [Related]
9. Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies.
Belldegrun AS; Klatte T; Shuch B; LaRochelle JC; Miller DC; Said JW; Riggs SB; Zomorodian N; Kabbinavar FF; Dekernion JB; Pantuck AJ
Cancer; 2008 Nov; 113(9):2457-63. PubMed ID: 18823034
[TBL] [Abstract][Full Text] [Related]
10. Population-based study of renal cell carcinoma in children in Germany, 1980-2005: more frequently localized tumors and underlying disorders compared with adult counterparts.
Selle B; Furtwängler R; Graf N; Kaatsch P; Bruder E; Leuschner I
Cancer; 2006 Dec; 107(12):2906-14. PubMed ID: 17109448
[TBL] [Abstract][Full Text] [Related]
11. [Value of bootstrapping for small series of patients: application to survival analysis for 26 patients followed for bilateral sporadic renal cell carcinoma].
Hupertan V; Rouprêt M; Chauchat JH; Bazin JP; Jacquemard A; Dufour B; Méjean A
Prog Urol; 2003 Dec; 13(6):1307-10. PubMed ID: 15000304
[TBL] [Abstract][Full Text] [Related]
12. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC
Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844
[TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma: assessment of key pathologic prognostic parameters and patient characteristics in 47,909 cases using the National Cancer Data Base.
Nese N; Paner GP; Mallin K; Ritchey J; Stewart A; Amin MB
Ann Diagn Pathol; 2009 Feb; 13(1):1-8. PubMed ID: 19118775
[TBL] [Abstract][Full Text] [Related]
14. Metastatic renal cancer and patient survival as a criterion of treatment response.
Stathopoulos GP; Koutantos J; Rigatos SK; Stathopoulos J; Batzios S; Batziou C
Oncol Rep; 2008 Feb; 19(2):477-81. PubMed ID: 18202797
[TBL] [Abstract][Full Text] [Related]
15. Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study.
Beisland C; Talleraas O; Bakke A; Norstein J
BJU Int; 2006 Apr; 97(4):698-702. PubMed ID: 16536756
[TBL] [Abstract][Full Text] [Related]
16. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
17. Vaccine therapy in patients with renal cell carcinoma.
Van Poppel H; Joniau S; Van Gool SW
Eur Urol; 2009 Jun; 55(6):1333-42. PubMed ID: 19201522
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
[TBL] [Abstract][Full Text] [Related]
19. Urinary collecting system invasion in renal cell carcinoma: incidence and long-term prognosis.
Schrader AJ; Rustemeier J; Varga Z; Hegele A; Olbert PJ; Frohme C; Hofmann R
Int J Urol; 2009 Sep; 16(9):718-22. PubMed ID: 19659680
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of combined treatment with interferon-alpha and active vitamin D3 for Japanese patients with metastatic renal cell carcinoma.
Obara W; Mizutani Y; Oyama C; Akaza H; Ishii N; Kohri K; Namiki M; Okuyama A; Shima H; Yokoyama M; Shuin T; Miki T; Watanabe Y; Fujioka T
Int J Urol; 2008 Sep; 15(9):794-9. PubMed ID: 18651865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]